ALT001 in Patients With Ischemic Stroke in the Sequelae Stage
ALT001 in Patients With Ischemic Stroke in the Sequelae Stage
Not yet recruiting · NCT07841496 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ALT001 in Patients With Ischemic Stroke in the Sequelae Stage | Ischemic Stroke in the Sequelae Stage | Not yet recruiting | Phase 2 | 2026-09-25 | NCT07841496 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Capital Medical University Affiliated Beijing Tiantan Hospital | Beijing | China | 2 |